Testing effectiveness (Phase 2)Study completedNCT05567952
What this trial is testing
Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir
Who this might be right for
COVID-19
Pfizer 436